Enanta Pharmaceuticals (ENTA) PT Lowered to $73 at JMP Securities, Following Clinical Business Update
Tweet Send to a Friend
JMP Securities analyst Roy Buchanan lowered the price target on Enanta Pharmaceuticals (NASDAQ: ENTA) to $73.00 (from $77.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
